• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

One-Third of COVID-19 Survivors May Develop a Neuropsychiatric Disorder Within Months of Infection
One-third of individuals diagnosed with COVID-19 developed a psychiatric or neurological problem within six months of their diagnosis, according to astudy published Tuesday inThe Lancet Psychiatry. The prevalence of a post-COVID neurologic or psychiatric diagnosis was even greater among individuals with severe illness who had required hospitalization.“Given the size of the pandemic and the chronicity of many of the diagnoses and their consequences (for example, dementia, stroke, and intracranial hemorrhage), substantial effects on health and social care systems are likely to occur,” wrote Maxime Taque, Ph.D., of the Un...
Source: Psychiatr News - April 7, 2021 Category: Psychiatry Tags: anxiety COVID-19 electronic health records hospitalizations mood disorders neuropsychiatric disorders The Lancet Psychiatry Source Type: research

NeurologicManifestations of Neglected Tropical Diseases (P4.295)
CONCLUSIONS: Neurological manifestations of NTDs cause significant morbidity and mortality, although data are limited. The evidence for treatments of neurologic complications is limited for most NTDs. Increased awareness of neurologic manifestations of NTDs can promote early identification and treatment, thereby contributing to ongoing elimination and eradication campaigns.Study Supported by: NADisclosure: Dr. Raibagkar has nothing to disclose. Dr. Berkowitz has received royalty payments from Medmaster and Oxford University Press. Dr. Pritt has nothing to disclose. Dr. Headley-Whyte has nothing to disclose. Dr. Mateen has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Raibagkar, P., Berkowitz, A., Pritt, B., Headley-Whyte, E. T., Mateen, F. Tags: Global Health and Infection Source Type: research